1-5 of 5
Andrew H. Sims
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy

Rachel Bleach, Stephen F. Madden, James Hawley, Sara Charmsaz, Cigdem Selli, Katherine M. Sheehan, Leonie S. Young, Andrew H. Sims, Pavel Souček, Arnold D. Hill, Marie McIlroy
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 3980–3989.
https://doi.org/10.1158/1078-0432.CCR-20-4135
Published: 15 July 2021
View article titled, Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy
Open the PDF for Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy in another window
Includes: Supplementary data
Journal Articles

Exercise Window Trial in Newly Diagnosed Breast Cancer–Letter

Andrew H. Sims, Melanie Leggate, Anna Campbell
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7609–7610.
https://doi.org/10.1158/1078-0432.CCR-19-2571
Published: 13 December 2019
View article titled, Exercise Window Trial in Newly Diagnosed Breast Cancer–Letter
Open the PDF for Exercise Window Trial in Newly Diagnosed Breast Cancer–Letter in another window
Journal Articles

Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer

Elspeth Ward, Damir Varešlija, Sara Charmsaz, Ailis Fagan, Alacoque L. Browne, Nicola Cosgrove, Sinéad Cocchiglia, Siobhan P. Purcell, Lance Hudson, Sudipto Das, Darran O'Connor, Philip J. O'Halloran, Andrew H. Sims, Arnold D. Hill, Leonie S. Young
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (15): 3692–3703.
https://doi.org/10.1158/1078-0432.CCR-17-2615
Published: 31 July 2018
View article titled, Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
Open the PDF for Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors

Damir Varešlija, Jean McBryan, Ailís Fagan, Aisling M. Redmond, Yuan Hao, Andrew H. Sims, Arran Turnbull, J.M. Dixon, Peadar Ó Gaora, Lance Hudson, Siobhan Purcell, Arnold D.K. Hill, Leonie S. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2765–2777.
https://doi.org/10.1158/1078-0432.CCR-15-1583
Published: 31 May 2016
View article titled, Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors
Open the PDF for Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors in another window
Includes: Supplementary data
Journal Articles

Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies

Dana Faratian, Annelien J.M. Zweemer, Yoko Nagumo, Andrew H. Sims, Morwenna Muir, Michael Dodds, Peter Mullen, Inhwa Um, Charlene Kay, Max Hasmann, David J. Harrison, Simon P. Langdon
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4451–4461.
https://doi.org/10.1158/1078-0432.CCR-10-2461
Published: 05 July 2011
View article titled, Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies
Open the PDF for Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies in another window
Includes: Supplementary data